V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004395 | 220001769 | 1.75 | 160.4 | Curative (C) | 2014-06-23 | 2014-06-23 | AML17 TRIAL | 01 | N | 220025965 | AML17 TRIAL |
| 220004396 | 220010881 | 1.73 | 78 | Curative (C) | 2015-10-13 | 2015-10-13 | AML17 TRIAL | 1 | N | 220025966 | AML17 TRIAL |
| 220004397 | 220001770 | 1.6 | null | Curative (C) | null | 2016-05-29 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025968 | CYTARABINE |
| 220004398 | 220001770 | null | null | Curative (C) | null | 2013-07-12 | AML17 TRIAL | N | N | 220025968 | AML17 TRIAL |
| 220004399 | 220015797 | null | 70.2 | null | null | 2014-08-19 | Cytarabine Low Dose | N | null | 220025971 | CYTARABINE |
| 220004400 | 220015797 | null | 61.5 | Palliative (P) | 2018-01-03 | 2018-01-03 | Cytarabine Low Dose | null | null | 220025971 | CYTARABINE |
| 220004401 | 220015797 | null | 73.4 | null | 2017-06-07 | 2017-06-18 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025971 | CYTARABINE |
| 220004402 | 220015797 | 1.7 | 86.8 | null | 2014-11-25 | 2014-11-26 | Trial Unspecified | Y | N | 220025971 | TRIAL |
| 220004403 | 220015797 | 1.91 | 119.8 | Curative (C) | 2016-09-21 | 2016-10-14 | Trial Unspecified | Y | N | 220025971 | TRIAL |
| 220004406 | 220015798 | 0 | 86.8 | Disease modification (D) | 2013-09-25 | 2013-09-25 | Trial Unspecified | Y | N | 220025983 | TRIAL |
| 220004407 | 220015798 | 1.63 | null | Palliative (P) | 2015-05-22 | 2015-05-26 | Cytarabine Low Dose | 02 | N | 220025983 | CYTARABINE |
| 220004408 | 220015798 | 1.68 | 53 | Curative (C) | 2014-11-30 | 2014-12-12 | AML17 TRIAL | N | N | 220025983 | AML17 TRIAL |
| 220004409 | 220021191 | 1.64 | 62.2 | Curative (C) | 2017-01-14 | 2017-01-14 | AML17 TRIAL | 1 | N | 220025988 | AML17 TRIAL |
| 220004410 | 220021191 | null | 64 | Palliative (P) | 2016-04-22 | 2016-06-30 | LI-1 TRIAL | Y | N | 220025988 | TRIAL |
| 220004411 | 220021191 | 1.6 | 75 | Palliative (P) | 2016-09-01 | 2016-09-03 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025988 | CYTARABINE |
| 220004412 | 220022146 | null | null | Curative (C) | null | 2015-08-30 | AML17 TRIAL | null | null | 220025995 | AML17 TRIAL |
| 220004413 | 220022146 | null | null | Curative (C) | null | 2014-06-12 | Cytarabine Low Dose | 02 | N | 220025995 | CYTARABINE |
| 220004414 | 220022146 | 1.77 | null | Curative (C) | null | 2016-03-26 | AML17 TRIAL | N | null | 220025995 | AML17 TRIAL |
| 220004415 | 220022146 | 1.66 | 78.5 | Curative (C) | 2015-01-05 | 2015-01-06 | AML17 TRIAL | 01 | N | 220025995 | AML17 TRIAL |
| 220004416 | 220022146 | 1.77 | 54.1 | Curative (C) | 2014-04-04 | 2014-04-04 | Trial Unspecified | Y | N | 220025995 | TRIAL |
| 220004417 | 220001772 | 1.68 | null | Palliative (P) | 2016-07-13 | 2016-07-16 | CYTARABINE | N | N | 220026006 | CYTARABINE |
| 220004418 | 220001772 | 1.85 | 60.5 | Disease modification (D) | 2017-04-01 | 2017-04-02 | Trial Unspecified | Y | N | 220026006 | TRIAL |
| 220004419 | 220001772 | 1.78 | 95.2 | Curative (C) | 2013-02-06 | 2013-02-22 | Trial Unspecified | null | N | 220026006 | TRIAL |
| 220004423 | 220001774 | 1.67 | 79 | Not known (9) | 2017-07-05 | 2017-07-07 | AML17 TRIAL | 01 | N | 220026015 | AML17 TRIAL |
| 220004424 | 220001775 | 1.78 | 88.5 | Palliative (P) | 2014-05-31 | 2014-06-05 | Cytarabine Low Dose | 02 | N | 220026016 | CYTARABINE |
| 220004425 | 220001775 | 0 | 91.9 | null | 2017-02-27 | 2017-03-03 | Trial Unspecified | N | N | 220026016 | TRIAL |
| 220004426 | 220001775 | 1.61 | null | Palliative (P) | null | 2016-05-17 | Cytarabine Low Dose | null | null | 220026016 | CYTARABINE |
| 220004427 | 220001775 | null | 65.3 | Palliative (P) | 2016-04-19 | 2016-04-27 | Cytarabine Low Dose | N | N | 220026016 | CYTARABINE |
| 220004428 | 220020266 | 1.78 | 89.6 | Not known (9) | 2016-04-17 | 2016-04-17 | Trial Unspecified | 01 | N | 220026023 | TRIAL |
| 220004429 | 220001776 | 0 | 80 | Disease modification (D) | 2015-04-19 | 2015-04-19 | Cytarabine Intrathecal (any age) | N | N | 220026028 | CYTARABINE |
| 220004430 | 220001776 | null | 79.8 | Adjuvant (A) | 2014-06-12 | 2014-06-21 | AML17 TRIAL | N | N | 220026028 | AML17 TRIAL |
| 220004431 | 220001776 | 1.86 | 62.1 | Curative (C) | null | 2017-06-26 | AML17 TRIAL | 02 | N | 220026028 | AML17 TRIAL |
| 220004432 | 220018657 | 1.68 | null | Palliative (P) | 2015-11-02 | 2015-11-02 | Cytarabine Low Dose | N | N | 220026033 | CYTARABINE |
| 220004433 | 220018657 | 1.77 | 89 | Not known (9) | 2016-08-31 | 2016-09-01 | AML17 TRIAL | 01 | N | 220026033 | AML17 TRIAL |
| 220004436 | 220001778 | null | 78.4 | Palliative (P) | 2014-05-28 | 2014-05-28 | Trial Unspecified | 01 | N | 220026041 | TRIAL |
| 220004437 | 220010889 | 1.78 | 102 | Palliative (P) | 2015-04-28 | 2015-04-29 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220026042 | CYTARABINE |
| 220004438 | 220001779 | 1.65 | 60 | Disease modification (D) | 2014-03-07 | 2014-03-07 | Trial Unspecified | 01 | N | 220026043 | TRIAL |
| 220004439 | 220001780 | null | null | Palliative (P) | 2014-01-15 | 2014-01-16 | Cytarabine Low Dose | null | null | 220026045 | CYTARABINE |
| 220004440 | 220001781 | null | 69 | null | 2013-03-11 | 2013-03-11 | AML17 TRIAL | Y | N | 220026046 | AML17 TRIAL |
| 220004441 | 220010890 | 1.8 | 100.4 | Curative (C) | 2013-06-16 | 2013-06-21 | LI-1 TRIAL | N | N | 220026051 | TRIAL |
| 220004442 | 220010890 | null | null | Not known (9) | null | 2017-08-29 | AML17 TRIAL | null | null | 220026051 | AML17 TRIAL |
| 220004443 | 220010890 | null | null | Palliative (P) | 2016-09-09 | 2016-09-09 | Cytarabine Low Dose | null | null | 220026051 | CYTARABINE |
| 220004444 | 220010890 | null | 46.4 | Palliative (P) | 2013-11-26 | 2013-11-26 | CYTARABINE | 2 | null | 220026051 | CYTARABINE |
| 220004448 | 220001783 | 1.83 | 95 | null | 2015-06-08 | 2015-06-08 | AML17 TRIAL | 02 | N | 220026066 | AML17 TRIAL |
| 220004449 | 220010892 | 1.66 | 114 | Palliative (P) | 2016-05-03 | 2016-05-03 | CYTARABINE | N | N | 220026067 | CYTARABINE |
| 220004450 | 220015805 | null | null | Palliative (P) | null | 2017-03-20 | Cytarabine Low Dose | null | null | 220026070 | CYTARABINE |
| 220004451 | 220015805 | null | 90 | null | 2014-12-28 | 2014-12-28 | Cytarabine Low Dose | N | N | 220026070 | CYTARABINE |
| 220004452 | 220015805 | 1.87 | 77.5 | null | 2016-05-25 | 2016-05-25 | Cytarabine Low Dose | N | N | 220026070 | CYTARABINE |
| 220004453 | 220015805 | 1.85 | 43.7 | Curative (C) | 2014-07-28 | 2014-07-28 | AML17 TRIAL | Y | N | 220026070 | AML17 TRIAL |
| 220004454 | 220001784 | 1.65 | 87.7 | Curative (C) | null | 2016-01-11 | Trial Unspecified | Y | null | 220026078 | TRIAL |